The use of aerosolized anticholinergics has not previously been emphasized as a cause of
pharmacologic pupillary dilation. The diagnosis can be confirmed by instillation of 1 percent …

There is a legend in textbooks of pharmacology and therapeutics that glaucomatous eyes
may be endangered by organic nitrate or nitrite vasodilator drugs of the type employed for …

Acute angle-closure glaucoma is an uncommon complication of inhaled ipratropium
bromide therapy for asthma. All previously reported cases have occurred in hospitalized …

In the course of doing simple lung-function tests on patients with chronic bronchitis, asthma,
or emphysema it became clear that many of those using bronchodilator aerosols were not …

Published evidence appears to be inadequate to establish whether there is significant
hazard in administering systemic medications with anticholinergic properties to patients who …

In 17 patients with glaucoma and in two with ocular hypertension, all of whom had not
responded satisfactorily to any conventional therapy, treatment was extended to include …

• A double-blind crossover study to determine the effects on intraocular pressure (IOP) and
blood pressure of topically instilled 0.125% and 0.25% solutions of clonidine hydrochloride …

A carbonic anhydrase inhibitor, acetazoleamide (Z-acetylamino-1, 3, 4, thiadiazole-S-
sulfonamide) was developed by Roblin and associates(1950). l The proprietary name of the …

Drop size Small eyedrops increase ocular bioavailability; the average eyedrop of about 40
p1 being too large. The conjunctival sac holds only 7 pl but can be expanded to 30 p1. A …

REPORTS 1 demonstrating the tension-lowering possibilities of adrenergic blocking agents
in glaucoma are occurring in the literature. There are several types of adrenergic blocking …